Cargando…

Exploring procedure duration and risk for serious adverse events during congenital cardiac catheterization

OBJECTIVES: While procedure length is considered an important metric for cardiothoracic surgical procedures, the relationship between procedure length and adverse events (AEs) in congenital cardiac catheterizations has little published data available. Furthermore, most existing congenital cardiac ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Mary J, Lydon, Elizabeth, Gauvreau, Kimberlee, Jenkins, Kathy J, Slater, David, Bergersen, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835933/ https://www.ncbi.nlm.nih.gov/pubmed/36643781 http://dx.doi.org/10.1136/bmjsit-2022-000142

Ejemplares similares

Procedural Risk in Congenital Cardiac Catheterization (PREDIC(3)T)
por: Quinn, Brian P., et al.
Publicado: (2021)

Incidence and Management of Life-Threatening Adverse Events During Cardiac Catheterization for Congenital Heart Disease
por: Lin, C. Huie, et al.
Publicado: (2013)

Changes in Practice/Outcomes of Pediatric/Congenital Catheterization in Response to the First Wave of COVID
por: Quinn, Brian, et al.
Publicado: (2022)

Development of a Charge Adjustment Model for Cardiac Catheterization
por: Brennan, Andrew, et al.
Publicado: (2014)

Development and Validation of an Agency for Healthcare Research and Quality Indicator for Mortality After Congenital Heart Surgery Harmonized With Risk Adjustment for Congenital Heart Surgery (RACHS‐1) Methodology
por: Jenkins, Kathy J., et al.
Publicado: (2016)

Aspiration Is Associated with Poor Treatment Response in Pediatric Pulmonary Vein Stenosis
por: Niccum, Maria, et al.
Publicado: (2021)

Procedure in the event of serious accidents
Publicado: (1974)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Longer Exposure to Left-to-Right Shunts Is a Risk Factor for Pulmonary Vein Stenosis in Patients with Trisomy 21
por: Choi, Connie, et al.
Publicado: (2021)

Infrastructure Availability for the Care of Congenital Heart Disease Patients and Its Influence on Case Volume, Complexity and Access Among Healthcare Institutions in 17 Middle-Income Countries
por: Wamala, Isaac, et al.
Publicado: (2021)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

Serious Adverse Events in Pediatric Procedural Sedation Before and After the Implementation of a Pre-Sedation Checklist
por: Librov, Simona, et al.
Publicado: (2020)

Anesthesia for cardiac catheterization procedures
por: Hamid, A
Publicado: (2014)

Diagnostic quality of steady state free precession imaging of cardiac valve morphology in pediatric/congenital heart disease
por: Benavidez, Oscar J, et al.
Publicado: (2009)

Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Failure to Rescue as an Outcome Metric for Pediatric and Congenital Cardiac Catheterization Laboratory Programs: Analysis of Data From the IMPACT Registry
por: O'Byrne, Michael L., et al.
Publicado: (2019)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Stroke in Adults With Coarctation of the Aorta: A National Population‐Based Study
por: Pickard, Sarah S., et al.
Publicado: (2018)

Surveillance of serious adverse events following immunization in resource poor settings
por: Breugelmans, Gabrielle J, et al.
Publicado: (2011)

Cardiac Catheterization in Congenital Heart Disease
por: Gray, Frank
Publicado: (1949)

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
por: Awadzi, Kwablah
Publicado: (2003)

Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring
por: Donzelli, Alberto
Publicado: (2019)

Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
por: Kimura, Goji, et al.
Publicado: (2015)

Impact of the neutral position and rotation of the head in ultrasound-guided internal jugular vein catheterization on duration of procedure and complications
por: Kurt, M, et al.
Publicado: (2014)

Pulmonary Vein Stenosis: A Rare Disease with a Global Reach
por: Schramm, Jennifer, et al.
Publicado: (2021)

A Cancer Patient’s Experience With a Rare But Serious Adverse Event
por: RayChaudhury, Amlan
Publicado: (2019)

An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
por: Hosoda, Tomohiro, et al.
Publicado: (2019)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Cardiac catheterization procedures in pediatric patients undergoing extracorporeal membrane oxygenation cardiac catheterization, ECMO
por: Güzeltaş, Alper, et al.
Publicado: (2017)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

Serious adverse events of older adults in nursing home and community intervention trials
por: Datta, Rupak, et al.
Publicado: (2017)

Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
por: Huesch, Marco D.
Publicado: (2017)

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers
por: Williams, S. Elizabeth, et al.
Publicado: (2013)

Serious adverse event: late neurotropic disease associated with yellow fever vaccine
por: de Oliveira, Henrique Souza Barros, et al.
Publicado: (2020)

Cardiac and vascular serious adverse events following tixagevimab–cilgavimab – Author's reply
por: Maselkar, Sheetal, et al.
Publicado: (2023)

Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors
por: Chen, Xiujin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7d3g4vbl6t9rfsfnp89q3hl7n